ARS Pharmaceuticals announces agreement with ALK to commercialize neffy
ARS Pharmaceuticals has entered a licensing agreement with ALK-Abello A/S for the exclusive commercialization of neffy in Europe, Canada, and other regions outside the U.S. ARS Pharma will retain neffy rights in the U.S.